期刊文献+

重型颅脑损伤患者气管切开术后肺部感染的分析及护理对策 被引量:17

Related factors for pulmonary infections in patients with severe cerebral traumas after tracheotomy and nursing countermeasures
原文传递
导出
摘要 目的总结分析重型颅脑损伤患者气管切开术后并发肺部感染相关因素及护理对策。方法回顾性总结景德镇第二人民医院神经外科重症监护病房2007年6月-2010年12月60例重型颅脑损伤患者并气管切开术后肺部感染资料。结果 60例重型颅脑损伤患者气管切开术后并发肺部感染48例,感染率为80.0%;检出57株病原菌,其中革兰阴性菌35株,占61.4%,革兰阳性菌16株,占28.1%,真菌6株,占10.5%。结论重型颅脑损伤气管切开术后患者是肺部感染的高危人群,要采取及时有效的护理对策,以降低肺部感染的发生。 OBJECTIVE To summarize the related factors for severe head injury patients with concurrent pulmonary infection after tracheotomy and nursing countermeasures. METHODS A retrospective summary was carried out based on the clinical data of 60 cases of severe head injury patients with pulmonary infections after tracheotomy in Jingdezhen second people′s hospital neurosurgery ICU from Jun 2006 to 2010 Dec. RESULTS Among 60 cases wiht severe head injury patients after tracheotomy,concurrent lung infections were in 48 cases with infection rate of 80.0%.57 strains of pathogens were detected,among which 35 strains were Gram-positive bacteria,accounting for 61.4%,16 strains were Gram-negative bacteria,accounting for 28.1%,6 strains were fungi,accounting for 10.5%. CONCLUSION Severe head injury patients with pulmonary infection after tracheotomy are the high-risk groups,it should timely adopt the effective nursing countermeasures to reduce the pulmonary infection.
作者 吴美华
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2011年第23期4978-4979,共2页 Chinese Journal of Nosocomiology
关键词 重型颅脑损伤 气管切开术后 肺部感染 护理对策 Severe cerebral injury Tracheotomy Pulmonary infection Nursing countermeasures
  • 相关文献

参考文献4

二级参考文献32

  • 1李涛,熊自忠,沈继录,周强,徐元宏,王中新.大肠埃希菌与克雷伯菌属细菌qnr基因的检测[J].检验医学,2005,20(2):112-114. 被引量:35
  • 2张璟,孙自镛,马越,李景云,金少鸿.152株肺炎链球菌的耐药性及血清分型研究[J].中华医院感染学杂志,2007,17(4):468-471. 被引量:36
  • 3刘学源,陈玉娟,杜望春,杜新鲁.脑出血患者并发医院感染的临床研究[J].中华医院感染学杂志,2007,17(6):668-670. 被引量:26
  • 4Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Eighteenth informational supplement. CIGI documents M100-S18. CLSI/NCCLS,2008.
  • 5Granger D, Boily-Larouche G, Turgeon P, et al. Molecular characteristics of pbpla and pbp2b in clinical Streptococcus pneurnoniae isolates in Quebec. Canada[J]. J Antimierob Chemoter,2006,57(1):61-70.
  • 6Schwaber MJ, Navon-Venezia S, Kaye KS, et al. Clinical and economic impact of bacteremia with extended-spectrum-β-lactamases-producing Enterobacteriaeeae[J]. Antimierob Agents Chemother, 2006,50(4) : 1257-1262.
  • 7Tumbarello M, Spanu T, Sanguinetti M, et al. Bloodstream infections caused by extended-spectrum-β-lactamases-producing Klebsiella pneumoniae :risk factors, molecular epidemiol- ogy and clinical outcome[J]. Antimicrob Agents Chemother, 2006,50(2):498 504.
  • 8Wang H, Kelkar S, Wu WY, etal. Clinical isolates of Enterobacteriaceae producing extended-spectrum β-lactamases:prevalence of CTX-M 3 at a hospital in China[J]. Antimicrob Agents Chemother, 2003,47(2) : 790-793.
  • 9Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically[S]. Seventh edition. Approved Standard. CLSI documents M7 A7. CLSI,2006.
  • 10Drlica K,Malik M.Fluoroquinolones:action and resistance[J].Curr Top Med Chem,2003,3(3):249-282.

共引文献440

同被引文献105

引证文献17

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部